Most patients hospitalized with COVID-19 pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, Cedars-Sinai Medical Center reported Tuesday based on a new study. Outcomes for patients who received the drug, tocilizumab, included reduced inflammation, oxygen requirements, blood pressure support and risk of death, compared with published reports […]